1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Lung Injury Global Clinical Trials Review, H2, 2015

Lung Injury Global Clinical Trials Review, H2, 2015

  • July 2015
  • -
  • Global Data
  • -
  • 80 pages

Lung Injury Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H2, 2015" provides an overview of Lung Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Lung Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Lung Injury Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Lung Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Lung Injury to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Lung Injury to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Lung Injury 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Lung Injury Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline Plc 33
Clinical Trial Overview of GlaxoSmithKline Plc 33
Pierrel S.p.A. 34
Clinical Trial Overview of Pierrel S.p.A. 34
Faron Pharmaceuticals Oy 35
Clinical Trial Overview of Faron Pharmaceuticals Oy 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
CareGroup, Inc. 38
Clinical Trial Overview of CareGroup, Inc. 38
Asklepion Pharmaceuticals, LLC 39
Clinical Trial Overview of Asklepion Pharmaceuticals, LLC 39
Apeptico Forschung und Entwicklung GmbH 40
Clinical Trial Overview of Apeptico Forschung und Entwicklung GmbH 40
Altor BioScience Corporation 41
Clinical Trial Overview of Altor BioScience Corporation 41
Abbott Laboratories 42
Clinical Trial Overview of Abbott Laboratories 42
Clinical Trial Overview of Top Institutes / Government 43
National Heart, Lung, and Blood Institute 43
Clinical Trial Overview of National Heart, Lung, and Blood Institute 43
Belfast Health and Social Care Trust 44
Clinical Trial Overview of Belfast Health and Social Care Trust 44
Academic Medical Center 45
Clinical Trial Overview of Academic Medical Center 45
Mayo Clinic 46
Clinical Trial Overview of Mayo Clinic 46
Royal Group of Hospitals Trust 47
Clinical Trial Overview of Royal Group of Hospitals Trust 47
Shanghai Changzheng Hospital 48
Clinical Trial Overview of Shanghai Changzheng Hospital 48
Sichuan University 49
Clinical Trial Overview of Sichuan University 49
The 2nd Affiliated Hospital of Harbin Medical University 50
Clinical Trial Overview of The 2nd Affiliated Hospital of Harbin Medical University 50
University of Oklahoma 51
Clinical Trial Overview of University of Oklahoma 51
Vanderbilt University 52
Clinical Trial Overview of Vanderbilt University 52
Five Key Clinical Profiles 53
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 80

List of Tables
Lung Injury Therapeutics, Global, Clinical Trials by Region, 2015* 7
Lung Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Lung Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Lung Injury Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Lung Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Lung Injury to Respiratory Clinical Trials, G7 Countries (%), 2015* 15
Lung Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Lung Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Lung Injury to Respiratory Clinical Trials, E7 Countries (%), 2015* 18
Lung Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Lung Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Lung Injury Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Lung Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Lung Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Lung Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Lung Injury Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Lung Injury Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Lung Injury Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Lung Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Lung Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 33
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Pierrel S.p.A., 2015* 34
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Faron Pharmaceuticals Oy, 2015* 35
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 36
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 37
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by CareGroup, Inc., 2015* 38
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Asklepion Pharmaceuticals, LLC, 2015* 39
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Apeptico Forschung und Entwicklung GmbH, 2015* 40
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Altor BioScience Corporation, 2015* 41
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 42
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015* 43
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Belfast Health and Social Care Trust, 2015* 44
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 45
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 46
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Group of Hospitals Trust, 2015* 47
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2015* 48
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Sichuan University, 2015* 49
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by The 2nd Affiliated Hospital of Harbin Medical University, 2015* 50
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2015* 51
Lung Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 52

List of Figures
Lung Injury Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Lung Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Lung Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Lung Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Lung Injury to Respiratory Clinical Trials, G7 Countries (%), 2015* 15
Lung Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Lung Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Lung Injury to Respiratory Clinical Trials, E7 Countries (%), 2015* 18
Lung Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Lung Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Lung Injury Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Lung Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Lung Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Lung Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Lung Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Lung Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.